Last Updated on eMC 05-07-2016 View medicine  | GlaxoSmithKline Consumer Healthcare Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Improved presentation of PIL

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC